Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2021-01-10
2023-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objective of this cohort follow-up is to:
1. Clinically characterize COVID patients who are positive for serological testing
2. Assess the socio-demographic, clinical and psychotropic determinants of a COVID diagnosis
3. Immunologically characterize COVID patients who are positive for serological testing
4. Exploring the links between susceptibility to COVID19 and erythrocytic blood groups
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 and Psychotic Symptoms in France
NCT04356885
The Immune System and Psychiatric Disorders
NCT00184418
PSYCHIATRIC Disorders and Covid-19
NCT04358042
Peripheral Immune System in Individuals With Schizophrenia
NCT05109065
Biocollection on Peripheral Inflammation
NCT05934474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A Comparison of COVID patients versus no COVID patients will be based on a clinical examination (psychiatric, somatic) and blood samples collected at J0 and J15.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
psychiatric patient
patients who are hospitalized in psychiatric department
COVID19 immunization testing
serological COVID19 test with confirmation at J15 during hospitalization
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COVID19 immunization testing
serological COVID19 test with confirmation at J15 during hospitalization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalized in one of the participating psychiatric wards during the inclusion period
* Signed informed consent
Exclusion Criteria
* Patient under safeguard of justice
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marion LEBOYER, PHD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique des Hopitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique - Hôpitaux de Paris
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP200553
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.